All Issue

2023 Vol.53, Issue 2

Review Article

Current Advances in Antiviral Potential of Artemisia Against Major Viral Infections
Fredmoore Legaspi Orosco123*
1Virology and Vaccine Institute of the Philippines Program, Industrial Technology Development Institute, Department of Science and Technology, Bicutan, Taguig City, Philippines 1634, Philippines
2S&T Fellows Program, Department of Science and Technology, Bicutan, Taguig City, Philippines 1634, Philippines
3Department of Biology, College of Arts and Sciences, University of the Philippines Manila, Manila, Philippines 1000, Philippines
*orosco.fredmoore@gmail.com; florosco@up.edu.ph
31 December 2023. pp. 61-73
PDF XML Citation
Abstract

Artemisia, a genus rich in bioactive compounds, has garnered considerable attention for its potential antiviral properties. This review consolidates current research on Artemisia’s efficacy against a spectrum of viral infections, encompassing SARS- CoV-2, human and avian influenza viruses, human immunodeficiency virus (HIV), hepatitis B virus (HBV), and herpes simplex virus (HSV). This comprehensive review aims to synthesize key findings regarding the antiviral potential of Artemisia, elucidating the mechanisms of action, highlighting significant outcomes from experimental studies, and providing insights into the gaps and future directions for research in this domain. Artemisia exhibits substantial antiviral activity across diverse viral families. Mechanisms range from direct interference with viral replication to modulation of host immune responses. In conclusion, the collective evidence underscores Artemisia as a promising candidate for antiviral interventions. The diverse array of compounds found in different Artemisia species demonstrates efficacy against a range of viruses. However, while substantial progress has been made, further research, especially clinical trials, is crucial to validate Artemisia’s therapeutic potential and facilitate its integration into mainstream antiviral strategies. This review serves as a roadmap for future investigations in harnessing Artemisia’s antiviral prowess.

Keywords
Artemisia
Antiviral activity
Bioactive compounds
Drug discovery
Natural product
References
1

Singh M, de Wit E. Antiviral agents for the treatment of COVID-19: Progress and challenges. Cell Rep Med 2022;3:100549.

10.1016/j.xcrm.2022.10054935474740PMC8831133
2

Koparde AA, Doijad RC, Magdum CS, Koparde AA, Doijad RC, Magdum CS. Natural products in drug discovery. In Pharmacogn-Med Plants. IntechOpen, 2019.

3

Akram M, Tahir IM, Shah SMA. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review. Phytother Res 2018;32:811-22.

10.1002/ptr.602429356205
4

Allam SF, Soudy BA, Hassan AS, Ramadan MM, Baker DA. How do mentha plants induce resistance against Tetranychus urticae (Acari: Tetranychidae) in organic farming? J Plant Prot Res 2018;58:265-75.

5

Koul B, Taak P, Kumar A, Khatri T, Sanyal I. The Artemisia genus: A review on traditional uses, phytochemical constituents, pharmacological properties and germplasm Conservation. J Glycomics Lipidomics 2018;07:1000142.

10.4172/2153-0637.1000142
6

Bora KS, Sharma A. The genus Artemisia: A comprehensive review. Pharm Biol 2011;49:101.

10.3109/13880209.2010.49781520681755
7

Orosco FL. Current progress in diagnostics, therapeutics, and vaccines for African swine fever virus. Vet Integr Sci 2023;21:751-81.

10.12982/VIS.2023.054
8

Khan FA, Khan NM, Ahmad S Nasruddin, Aziz R, Ullah I, et al. Phytochemical profiling, antioxidant, antimicrobial and cholinesterase inhibitory effects of essential oils isolated from the leaves of Artemisia scoparia and Artemisia absinthium. Pharmaceuticals 2022;15:1221.

10.3390/ph1510122136297333PMC9607455
9

Orosco F. Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus. Open Vet J 2023;13:1056-70.

10.5455/OVJ.2023.v13.i9.137842102PMC10576574
10

Taleghani A, Emami SA, Tayarani-Najaran Z. Artemisia: A promising plant for the treatment of cancer. Bioorg Med Chem 2020;28:115180.

10.1016/j.bmc.2019.11518031784199
11

Talman AM, Clain J, Duval R, Ménard R, Ariey F. artemisinin bioactivity and resistance in malaria parasites. Trends Parasitol 2019;35:953-63.

10.1016/j.pt.2019.09.00531699532
12

Liu X, Cao J, Huang G, Zhao Q, Shen J. biological activities of artemisinin derivatives beyond malaria. Curr Top Med Chem 2019;19:205-22.

10.2174/156802661966619012214421730674260
13

Guibourt NJBG. Historia natural de las drogas simples o... Imp. de D.Manuel A.Gil;1852.

14

Al-Sanafi AE. The pharmacological importance of Artemsia campestris-A review. Asian J Pharm Res 2015;5:88-92.

15

Apaza Ticona L, Bermejo P, Guerra JA, Abad MJ, Beltrán M, Martín Lázaro R, et al. Ethanolic extract of Artemisia campestris subsp. glutinosa (Besser) Batt. inhibits HIV-1 replication in vitro through the activity of terpenes and flavonoids on viral entry and NF-κB pathway. J Ethnopharmacol 2020;263:113163.

10.1016/j.jep.2020.11316332758575PMC7397943
16

Breverton T, Culpeper N. breverton's complete herbal: A book of remarkable plants and their uses. London: Quercus;2011.

17

Palmer G. Shuswap indian ethnobotany. Syesis 1975;8:29-81.

18

Kadi I, Ouinten M, Gourine N, Yousfi M. Synergistic antinociceptive activity of combined aqueous extracts of Artemisia campestris and Artemisia herba-alba in several acute pain models. Nat Prod Res 2019;33:875-8.

10.1080/14786419.2017.141080229210306
19

Ghlissi Z, Sayari N, Kallel R, Bougatef A, Sahnoun Z. Antioxidant, antibacterial, anti-inflammatory and wound healing effects of Artemisia campestris aqueous extract in rat. Biomed Pharmacother 2016;84:115-22.

10.1016/j.biopha.2016.09.01827643553
20

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934-43.

10.1001/jamainternmed.2020.099432167524PMC7070509
21

Efferth T. Beyond malaria: The inhibition of viruses by artemisinin-type compounds. Biotechnol Adv 2018;36:1730-7.

10.1016/j.biotechadv.2018.01.00129305894
22

Rolta R, Salaria D, Sharma P Sharma B, Kumar V, Rathi B, et al. Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua inhibit spike protein of SARS-CoV-2 binding to ACE2 receptor: In silico approach. Curr Pharmacol Rep 2021;7:135-49.

10.1007/s40495-021-00259-434306988PMC8279807
23

Cao R, Hu H, Li Y, Wang X, Xu M, Liu J, et al. Anti-SARS-CoV-2 potential of artemisinins in vitro. ACS Infect Dis 2020;6:2524-31.

10.1021/acsinfecdis.0c0052232786284
24

Nair MS, Huang Y, Fidock DA, Polyak SJ, Wagoner J, Towler MJ, et al. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants. 2021:274:114016.

10.1016/j.jep.2021.11401633716085PMC7952131
25

Gendrot M, Duflot I, Boxberger M, Delandre O, Jardot P, Le Bideau M, et al. Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate. Int J Infect Dis 2020;99:437-40.

10.1016/j.ijid.2020.08.03232805422PMC7426697
26

Li G, Yuan M, Li H, Deng C, Wang Q, Tang Y, et al. Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial. Int J Antimicrob Agents 2021;57:106216.

10.1016/j.ijantimicag.2020.10621633152450PMC7605811
27

Evans RM, Lippman SM. Shining light on the COVID-19 pandemic: A vitamin D receptor checkpoint in defense of unregulated wound healing. Cell Metab 2020;32:704-9.

10.1016/j.cmet.2020.09.00732941797PMC7486067
28

Orosco FL. Immune evasion mechanisms of porcine epidemic diarrhea virus: A comprehensive review. Vet Integr Sci 2024;22:171-92.

29

Cao Y, Feng YH, Gao LW, Li XY, Jin QX, Wang YY, et al. Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo. Int Immunopharmacol 2019;70:110-6.

10.1016/j.intimp.2019.01.04130798159
30

Trieu V, Saund S, Rahate PV, Barge VB, Nalk S, Windlass H, et al. Targeting TGF-β pathway with COVID-19 drug candidate ARTIVeda/PulmoHeal accelerates recovery from mild-moderate COVID-19. Clin Invest 2021;11:10-8.

10.1101/2021.01.24.21250418
31

Richard M, van den Brand JMA, Bestebroer TM, Lexmond P, de Meulder D, Fouchier RAM, et al. Influenza A viruses are transmitted via the air from the nasal respiratory epithelium of ferrets. Nat Commun 2020;11:766.

10.1038/s41467-020-14626-0PMC7005743
32

Mahedi MRA, Rawat A, Rabbi F, Babu KS, Tasayco ES, Areche F, et al. Understanding the global transmission and demographic distribution of Nipah virus (NiV). Res J Pharm Technol 2023;16:3588-94.

10.52711/0974-360X.2023.00592
33

Motlhatlego KE, Mehrbod P, Fotouhi F, Abdalla MA, Eloff JN, McGaw LJ. Anti-influenza A virus activity of two Newtonia species and the isolated compound myricetin-3-o-rhamnoside. BMC Complement Med Ther 2021;21:92.

10.1186/s12906-021-03250-033726731PMC7961164
34

Hegazy A, Mostafa I, Elshaier YAMM, Mahmoud SH, Abo Shama NM, Shehata M, et al. robust antiviral activity of santonica flower extract (Artemisia cina) against avian and human influenza A viruses: In vitro and chemoinformatic studies. ACS Omega 2022;7:41212-23.

10.1021/acsomega.2c0486736406485PMC9670689
35

Ponticelli M, Bellone ML, Parisi V, Iannuzzi A, Braca A, de Tommasi N, et al. Specialized metabolites from plants as a source of new multi-target antiviral drugs: a systematic review. Phytochem Rev 2023;22:615-93.

10.1007/s11101-023-09855-237359711PMC10008214
36

Nigam M, Atanassova M, Mishra AP, Pezzant R, Devkota HP, Plygun S, et al. Bioactive compounds and health benefits of Artemisia species. Nat Prod Commun 2019;14:1934578X19850354.

10.1177/1934578X19850354
37

Yong J, Aisa HA. chemical modification of rupestonic acid and preliminarily in vitro antiviral activity against influenza A3 and B viruses. Bull Korean Chem Soc 2011;32:1293-7.

10.5012/bkcs.2011.32.4.1293
38

Ou L, Qin K, Yang ZX, Bie MJ. The effects and mechanisms of dihydroartemisinin on influenza A Virus H1N1 induces TNF-α and IL-6 expression in bronchial epithelial cells. Sichuan Da Xue Xue Bao Yi Xue Ban 2020;51:171-7.

39

Lubbe A, Seibert I, Klimkait T, van der Kooy F. Ethnopharmacology in overdrive: The remarkable anti-HIV activity of Artemisia annua. J Ethnopharmacol 2012;141:854-9.

10.1016/j.jep.2012.03.02422465592
40

Ho WE, Peh HY, Chan TK, Wong WS. Artemisinins: Pharmacological actions beyond anti-malarial. Pharmacol Ther 2014;142:126-39.

10.1016/j.pharmthera.2013.12.00124316259
41

Oguariri RM, Adelsberger JW, Baseler MW, Imamichi T. Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication. Virus Res 2010;153:269-76.

10.1016/j.virusres.2010.08.01820800626PMC2956596
42

Jana S, Iram S, Thomas J, Hayat MQ, Pannecouque C, Dehaen W. Application of the triazolization reaction to afford dihydroartemisinin derivatives with anti-HIV activity. Molecules 2017;22:303.

10.3390/molecules2202030328218680PMC6155659
43

Efferth T, Marschall M, Wang X, Huong SM, Hauber I, Olbrich A, et al. Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses. J Mol Med 2002;80:233-42.

10.1007/s00109-001-0300-811976732
44

Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of Hepatitis B virus infection and impact of vaccination on disease. Clin Liver Dis 2016;20:607-28.

10.1016/j.cld.2016.06.006PMC5582972
45

Orosco F. Recent advances in peptide-based nanovaccines for re-emerging and emerging infectious diseases. J Adv Biotechnol Exp Ther 2024;7:106-17.

10.5455/jabet.2024.d10
46

Tsai E. Review of Current and potential treatments for chronic Hepatitis B virus infection. Gastroenterol Hepatol 2021;17:367-76.

47

Khalil MAM, Khalil MAU, Khan TFT, Tan J. Drug-induced hematological cytopenia in kidney transplantation and the challenges it poses for kidney transplant physicians. J Transplant 2018;2018:e9429265.

10.1155/2018/9429265PMC6093016
48

Su KH, Su SY, Ko CY, Cheng YC, Huang SS, Chao J. Ethnopharmacological survey of traditional chinese medicine pharmacy prescriptions for dysmenorrhea. Front Pharmacol 2021;12:746777.

10.3389/fphar.2021.746777PMC8724257
49

Chizzola R, Gansinger D. Chemical composition and antioxidant activity of Artemisia argyi essential oil and hydrolate. Compounds 2023;3:521-31.

10.3390/compounds3030037
50

Gong PY, Yuan ZX, Gu JJ, Tan R, Li JC, Ren Y, et al. anti-HBV activities of three compounds extracted and purified from Herpetospermum seeds. Molecules 2017;22:14.

10.3390/molecules2201001428035986PMC6155818
51

Zhang Z, Fu X, Wang Y, Wang J, Feng S, Zhao Z, et al. In vivo anti-hepatitis B activity of Artemisia argyi essential oil-loaded nanostructured lipid carriers. Study of its mechanism of action by network pharmacology and molecular docking. Phytomedicine 2023;116:154848.

10.1016/j.phymed.2023.154848
52

Laine RF, Albecka A, van de Linde S, Rees EJ, Crump CM, Kaminski CF. Structural analysis of herpes simplex virus by optical super-resolution imaging. Nat Commun 2015;6:5980.

10.1038/ncomms698025609143PMC4338551
53

Li W, Wang XH, Luo Z, Liu LF, Yan C, Yan CY, et al. Traditional Chinese Medicine as a Potential Source for HSV-1 Therapy by Acting on Virus or the Susceptibility of Host. Int J Mol Sci 2018;19:3266.

10.3390/ijms1910326630347851PMC6213986
54

Richards CM, Case R, Hirst TR, Hill TJ, Williams NA. protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice. J Virol 2003;77:6692-9.

10.1128/JVI.77.12.6692-6699.2003PMC156198
55

Kolawole OM, Amuda OO, Nzurumike C, Suleiman MM, Ikhevha Ogah J. Seroprevalence and co-infection of human immunodeficiency virus (HIV) and herpes simplex virus (HSV) among pregnant women in Lokoja, North-Central Nigeria. Iran Red Crescent Med J 2016;18:e25284.

10.5812/ircmj.2528428180012PMC5286443
56

Silva GS, Richards GA, Baker T, Amin PR. Encephalitis and myelitis in tropical countries: Report from the task force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine. J Crit Care 2017;42:355-9.

10.1016/j.jcrc.2017.11.001
57

James SH, Prichard MN. Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance. Curr Opin Virol 2014;8:54-61.

10.1016/j.coviro.2014.06.00325036916
58

Orosco FL. Breaking the chains: Advancements in antiviral strategies to combat Nipah virus infections. Int J One Health 2023:122-133.

10.14202/IJOH.2023.122-133
59

Xiao J, Liu P, Hu Y, Guo Y, Sun P, Zheng J, et al. Antiviral activities of Artemisia vulgaris L. extract against herpes simplex virus. Chin Med 2023;18:21.

10.1186/s13020-023-00711-136855145PMC9972753
60

Liu P, Zhong L, Xiao J, Hu Y, Liu T, Ren Z, et al. Ethanol extract from Artemisia argyi leaves inhibits HSV-1 infection by destroying the viral envelope. Virol J 2023;20:8.

10.1186/s12985-023-01969-5PMC9841929
Information
  • Publisher :The Korean Society for Microbiology and The Korean Society of Virology
  • Publisher(Ko) :대한미생물학회‧대한바이러스학회
  • Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
  • Volume : 53
  • No :2
  • Pages :61-73
  • Received Date : 2023-11-24
  • Revised Date : 2023-12-27
  • Accepted Date : 2023-12-28
  • DOI :https://doi.org/10.4167/jbv.2023.53.2.061
Journal Informaiton JOURNAL OF BACTERIOLOGY AND VIROLOGY JOURNAL OF BACTERIOLOGY AND VIROLOGY
  • NRF
  • 임플란트학회 전용 배너
  • KOFST
  • crossref crossmark
  • crossref cited-by
  • crossref funder-registry
  • crosscheck
  • orcid
  • open access
  • ccl
Journal Informaiton Journal Informaiton - close